hTERT and IGF-1R Proteins Expression in Response to Treatment in Patients with HPV Alpha 9-Positive Cervical Cancer
Radiation Research · 07.03.2023 · 199 (5) · 452-459
DOI: 10.1667/rade-22-00121.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation Research, erschienen am 07.03.2023. Verfasst von Pablo Moreno-Acosta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Research Group, Instituto Nacional de Cancerología, Calle 1 # 9-85, Bogotá, Colombia. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Telomerase. Die Arbeit nennt 65 Literaturangaben.
Abstract (Originalsprache)
Human papillomavirus (HPV) infection is strongly associated with cervical cancer (CC). Genomic alterations caused by viral infection and subsequent dysregulation of cellular metabolism under hypoxic conditions could influence the response to treatment. We studied a possible influence of IGF-1Rb, hTERT, HIF1a, GLUT1 protein expression, HPV species presence and relevant clinical parameters on the response to treatment. In 21 patients, HPV infection and protein expression were detected using GP5+/GP6+PCR-RLB and immunohistochemistry, respectively. The worse response was associated with radiotherapy alone compared with chemoradiotherapy (CTX-RT), anemia and HIF1a expression. HPV16 type was the most frequent (57.1%) followed by HPV-58 (14.2%) and HPV-56 (9.5%). The HPV alpha 9 species was the most frequent (76.1%) followed by alpha 6 and alpha 7. IGF-1Rb (85.7%), HIF1a (61.9%), GLUT1 (52.3%), and hTERT expression [cytoplasm and nucleus (90.4%)] were detected. The MCA factorial map showed different relationships, standing out, expression of hTERT and alpha 9 species HPV, expression of hTERT and IGF-1Rb expression [Fisher's exact test (P = 0.04)]. A slight trend of association was observed between, GLUT1 and HIF1 a expression, hTERT and GLUT1 expression. A noteworthy finding was the subcellular localization of hTERT in the nucleus and cytoplasm of CC cells and its possible interaction with IGF-1R in presence of HPV alpha 9 species. Our findings suggest that the expression of HIF1a, hTERT, IGF-1Rb and GLUT1 proteins that interact with some HPV species may contribute to cervical cancer development, and the modu lation of treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Biology Research Group, Instituto Nacional de Cancerología, Calle 1 # 9-85, Bogotá, Colombia.
- Clinical, Molecular and Cellular Radiobiology Research Group, Instituto Nacional de Cancerología, Calle 1 # 9-85, Bogotá, Colombia.
- School of Computer Science, The University of Auckland, Auckland, New Zealand.
- Oncological Pathology Group, Instituto Nacional de Cancerología de Colombia, Calle 1 # 9-85, Bogotá, Colombia.
- Servei d'Oncologia Radioteràpica, Hospital de la Santa Creu i Sant Pau, Barcelona, España. Carrer de Sant Quintí, 89, 08026 Barcelona.
- Department of Radiotherapy, North Hospital, University Hospital of Saint-Etienne, Saint-Etienne, France; Saint Etienne Medicine University, Saint Etienne, France.
Zitieren
APA
Moreno-Acosta, P., Gamboa, O., González-Prieto, C., Romero-Rojas, A., Serra, J. B., Díaz, G. D., Malaver, G., Bouleftour, W., & Magné, N. (2023). hTERT and IGF-1R Proteins Expression in Response to Treatment in Patients with HPV Alpha 9-Positive Cervical Cancer. Radiation Research, 199(5), 452-459. https://doi.org/10.1667/rade-22-00121.1
Vancouver
Moreno-Acosta P, Gamboa O, González-Prieto C, Romero-Rojas A, Serra JB, Díaz GD, et al. hTERT and IGF-1R Proteins Expression in Response to Treatment in Patients with HPV Alpha 9-Positive Cervical Cancer. Radiation Research. 2023;199(5):452-459. doi:10.1667/rade-22-00121.1
BibTeX
@article{MorenoAcosta2023,
author = {Moreno-Acosta, Pablo and Gamboa, Oscar and González-Prieto, Cristian and Romero-Rojas, Alfredo and Serra, Josep Balart and Díaz, German Dario and Malaver, Gina and Bouleftour, Wafa and Magné, Nicolas},
title = {hTERT and IGF-1R Proteins Expression in Response to Treatment in Patients with HPV Alpha 9-Positive Cervical Cancer},
journal = {Radiation Research},
year = {2023},
volume = {199},
number = {5},
pages = {452--459},
doi = {10.1667/rade-22-00121.1}
}
EUVIMED